Contribution of ultrasonography to endometrial cancer screening in patients with hereditary nonpolyposis colorectal cancer/Lynch syndrome

International Journal of Gynecological Cancer

Volumn 20, Issue 4, 2010, Pages 583-587

  Lécuru, Fabrice ^a,b   Huchon, Cyrille ^a,b   Metzger, Ulrike ^a,b   Bats, Anne Sophie ^a,b   Le Frère Belda, Marie Aude ^a,b   Olschwang, Sylviane ^c   Puig, Pierre Laurent ^a,b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT PAOLI CALMETTES   (France)

Author keywords

Colorectal neoplasms; Complex atypical endometrial hyperplasia; Diagnostic accuracy; Endometrial cancer; Hereditary nonpolyposis; Lynch syndrome; Sensitivity; Specificity; Ultrasonography

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; FEMALE; FOLLOW UP; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MISMATCH REPAIR; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THICKNESS; TRANSVAGINAL ECHOGRAPHY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; EARLY DETECTION OF CANCER; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; POSTMENOPAUSE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 77952273739     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181d7283a     Document Type: Article

References (17)

1. Watson P, Lynch H. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993;71:677-685.
2. Watson P, Vasen H, Mecklin JP, et al. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med. 1994;96:516-520. (Pubitemid 24184436)
3. Vasen H, Watson P, Mecklin JP, et al. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. Anticancer Res. 1994;14:1675-1678. (Pubitemid 24357004)
4. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105-110.
5. Olschwang S, Bonaiti C, Feingold J, et al. Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas. Bull Cancer. 2004;91:303-315.
6. Quehenberger F, Vasen H, van Houwelingen H. Risk of colorectal and endometrial cancer for carriers of mutations of hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet. 2005;42:491-496.
7. Vasen H, Möslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (HNPCC). J Med Genet. 2007;44:353-362.
8. www.nccn.org/JNCCN/toc/2010january.asp. Accessed February 16, 2010.
9. Dove-Edwin I, Boks D, Goff S, et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal cancer. Cancer. 2002;94:1708-1712.
10. Rijcken F, Mourits M, Kleibeuker J, et al. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol. 2003;91:74-80. (Pubitemid 37188596)
11. Renkonen-Sinisalo L, Bützow R, Leminen A, et al. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer. 2006;120:821-824.
12. Langer R, Pierce J, O'Halan C, et al. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. N Engl J Med. 1997;337:1792-1798.
13. Omnes S, Chatellier G, Durieux P, et al. Investigation of vaginal bleeding: a systematic review of literature and a decision analysis. ESGO Congress; 2003; Brussels, Belgium.
14. Duffy S, Jackson TL, Lansdown M, et al., ATAC Trialists' Group. The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy. Hum Reprod. 2005;20:294-301.
15. Persadie RJ. Ultrasonographic assessment of endometrial thickness: a review. J Obstet Gynaecol Can. 2002;24:131-136.
16. Agostini A, Shojaï R, Cravello L, et al. Endometrial biopsy during outpatient hysteroscopy: evaluation and comparison of two devices. Eur J Obstet Gynecol Reprod Biol. 2001;97:220-222.
17. Lecuru F, Le Frere Belda MA, Bats AS, et al. Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: a prospective study. Int J Gynecol Cancer. 2008;18:1326-1331; DOI:10.1111/j.1525-1438.2007.01188.